Check out this board. Even the best get snookered. Controversial health startup Theranos has barely any medical experts on its board of directors Lydia Ramsey Pflanzer Oct 16, 2015, 7:12 AM A Wall Street Journal report published Thursday suggests Theranos, the $10 billion health startup that says its blood tests can be done quickly using a single drop, has a few problems. In a follow-up article published later Thursday evening, The Journal reported that the company had stopped using its signature finger-prick blood test on all but one of its more than 240 blood tests at the request of government regulators who are looking into the company's technology. The company, which is unlike any other, also has a board whose makeup is unlike that of most other health companies. Its members are: George P. Shultz — former US secretary of state Gary Roughead — retired US Navy admiral William J. Perry — former US secretary of defense Sam Nunn — former US senator who served as chairman of the Senate Armed Services Committee and the Permanent Subcommittee on Investigations James N. Mattis — retired US Marine Corps general Richard Kovacevich — former CEO of Wells Fargo Henry A. Kissinger — former US secretary of state William H. Frist — heart and lung transplant surgeon and former US senator William H. Foege — former director of the Centers for Disease Control and Prevention Riley P. Bechtel — chairman of the board of the Bechtel Group Inc., a construction company Sunny Balwani — president and COO of Theranos Elizabeth Holmes — CEO and chairman of the board of Theranos To make sure we got all that: that's six former government officials, two former military leaders, two corporation leaders, two members of Theranos' leadership, and two men who graduated from medical school. As my colleague Kevin Loria writes over at Tech Insider: "The caliber of the board suggests that Theranos must have developed a transformative innovation, but other than Frist, who has not practiced medicine in many years, only Foege is a medical professional."